Xcout Intel
January Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to January Therapeutics, Inc. among healthtech companies — ranked by similarity to what January Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see January Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About January Therapeutics, Inc.
January Therapeutics, Inc. is a privately held biotechnology company founded in 2017 and based in California, focused on developing next-generation targeted anti-cancer therapies.
January Therapeutics, Inc. at a glance
January Therapeutics, Inc. is a healthtech company headquartered in United States. It has raised at least $1.6M across the 2 funding rounds on record. Its most recent funding round raised $1.2M in January 2019. Xcout recorded 9 job postings from January Therapeutics, Inc. in the last 90 days.
January Therapeutics, Inc. funding rounds
At least $1.6M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.2M | — | |
| Seed | $375,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at January Therapeutics, Inc.
Xcout recorded 9 job postings from January Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see January Therapeutics, Inc.'s hiring signals →
Top 12 January Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to January Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar healthtech company
FinalDose is a biotechnology research company headquartered in San Francisco, United States. It is developing the first programmable drug platform, which involves a single smart drug molecule designed to find diseased cells by their DNA for cancer therapy.
Biotech
Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to target specific antigens such as prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. In addition to its TRACTr pipeline, the company is also developing a Tumor Activated Immunomodulator (TRACIr) — a costimulatory bispecific candidate designed to enhance T cell anti-tumor activity by engaging with programmed death-ligand 1 and CD28. Furthermore, a specific focus for their EGFR-TRACTr program is addressing epidermal growth factor receptor, a target prevalent in many cancer types and already a focus of numerous approved monoclonal antibody treatments. Janux Therapeutics, Inc. was founded in 2017 and is headquartered in La Jolla, California.
Biotechnology
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Biotech
Alterome Therapeutics, Inc. is a clinical-stage precision oncology company headquartered in San Diego, California, founded in 2021. The privately held biotech firm focuses on developing targeted therapies to address genomically defined cancer drivers and intractable oncological targets.
Biotechnology
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
Biotechnology
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Biotechnology
TigaTx is a Boston-based biotechnology company founded in 2018 that is developing a pipeline of therapies targeting various cancer types and infectious diseases.
Biotechnology
Cleave Biosciences, Inc. is a biotechnology research company headquartered in California, focused on discovering and developing novel therapies that target protein homeostasis to treat cancer.
Healthcare
Eigen Therapeutics is a biotechnology company headquartered in Redwood City, California, focused on developing 'priming' therapies that make cancer easier to find and eliminate.
Biotechnology
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
Biotechnology
Turning Point Therapeutics is a clinical-stage precision oncology company based in San Diego, California, that designs and develops targeted cancer therapies. Founded in 2013, the company operates as a subsidiary of Bristol Myers Squibb following its acquisition in 2022.
Biotechnology
Layka Bio Inc. is a biotechnology company that develops novel cancer therapies targeting the biological mechanisms shared across most tumor types. The company identifies key drivers of cancer to create broad and effective treatments for patients with serious diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of January Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for January Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →